These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Expression of gelatinases A and B and their endogenous regulators in immortal and transformed fibroblasts]. Solov'eva NI, Vinokurova SV, Ryzhakova OS, Gureeva TA, Tsvetkova IV. Biomed Khim; 2009; 55(4):441-50. PubMed ID: 20000122 [Abstract] [Full Text] [Related]
3. [Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)]. Solovуeva NI, Timoshenko OS, Gureeva TA, Kugaevskaya EV. Biomed Khim; 2015; 61(6):694-704. PubMed ID: 26716740 [Abstract] [Full Text] [Related]
12. Glycogen synthase kinase-3β inactivation promotes cervical cancer progression, invasion, and drug resistance. Nath N, Rana A, Nagini S, Mishra R. Biotechnol Appl Biochem; 2022 Oct; 69(5):1929-1941. PubMed ID: 34554598 [Abstract] [Full Text] [Related]
13. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Díaz-Tejeda Y, Guido-Jiménez MC, López-Carbajal H, Amador-Molina A, Méndez-Martínez R, Gariglio-Vidal P, Lizano M, García-Carrancá A. Viruses; 2021 Jul 28; 13(8):. PubMed ID: 34452350 [Abstract] [Full Text] [Related]
15. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF, Wang N, Bi XN, Yu X, Xu XH, Wang YL, Zhao CQ, Luo B, Wang YK. Virol J; 2016 Apr 05; 13():60. PubMed ID: 27044426 [Abstract] [Full Text] [Related]